We use necessary cookies that allow our site to work. We also set optional cookies that help us improve our website. For more information about the types of cookies we use, visit our Cookies policy.

Cookie settings

Leishmaniasis cutaneous and visceral


What is Visceral leishmaniasis?

Visceral leishmaniasis (also known as kala-azar) affects people in Africa, Asia and Latin America. Programs reported 13,000 cases in 2022. Visceral leishmaniasis is caused by the infected bites of sandflies that breed in and around homes or farms.

If visceral leishmaniasis progresses, it attacks the immune system and affects the bone marrow and internal organs (including enlargement and impaired function of the spleen and liver), as well as causing irregular bouts of fever, substantial weight loss and anaemia. Without treatment, visceral leishmaniasis can have a fatality rate as high as 100% within two years.

The disease is linked to poverty.

WHO road map target:

Elimination as a public health problem by 2030

Key stats

  • Over 80%

    decrease in Indian subcontinent from 2015 to 2022

  • 13,000 cases

    reported in 2022

Number of visceral leishmaniasis cases reported by countries in 2022

Number of visceral leishmaniasis cases reported by year

What is Cutaneous leishmaniasis?

Cutaneous leishmaniasis affects people in the Americas, the Mediterranean basin, the Middle East and Central Asia. It is estimated that between 600 000 to 1 million new cases occur worldwide annually.

Cutaneous leishmaniasis(CL) is the most common form of leishmaniasis and causes skin lesions, mainly ulcers, on exposed parts of the body, leaving life-long scars and serious disability or stigma. In 2022 90% of new CL cases occurred in 11 countries: Afghanistan, Algeria, Brazil, Colombia, Iran, Iraq, Peru, Sri Lanka, the Syrian Arab Republic, Tunisia, and Yemen.

  • In 2022 90% of new CL cases

    occurred in 11 countries

  • 600,000 to 1 million

    estimated new cases annually

Number of cutaneous Leishmaniasis cases reported by country

Number of cutaneous leishmaniasis cases reported by year

Further information